CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion
Alkhatib G, et al. 1997. CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion. J. Biol. Chem. 272:19771-19776.
The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle
Blanpain C, et al. 2003. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 278:5179-5187.
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
Connor RI, Chen BK, Choe S, Landau NR. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
Dragic T, et al. 2000. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. U. S. A. 97:5639-5644.
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide
Gaertner H, et al. 2008. Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide. Proc. Natl. Acad. Sci. U. S. A. 105:17706-17711.
New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection
Garcia-Perez J, et al. 2011. New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection. J. Biol. Chem. 286:4978-4990.
Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity
Gosling J, et al. 1997. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. U. S. A. 94:5061-5066.
The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation
Govaerts C, et al. 2001. The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation. J. Biol. Chem. 276:13217-13225.
Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3
Govaerts C, et al. 2003. Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J. Biol. Chem. 278:1892-1903.
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors
Hartley O, et al. 2004. Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. Proc. Natl. Acad. Sci. U. S. A. 101:16460-16465.
An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells
Shimizu N, et al. 1999. An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells. J. Virol. 73:5231-5239.
Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach
Thiele S, et al. 2011. Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach. J. Biol. Chem. 286: 37543-37554.
